标普和纳斯达克内在价值 联系我们

Translational Development Acquisition Corp. TDAC NASDAQ

NASDAQ Capital Marke • Financial Services • Shell Companies • US • USD

SharesGrow Score
52/100
3/6 Pass
SharesGrow Intrinsic Value
$9.76
-7.9%

Translational Development Acquisition Corp. (TDAC) 是一家上市公司 属于 金融服务 板块,经营于 壳公司 行业. 公司总部位于 New York City, NY, 美国. 现任CEO为 Michael Hoffman.

TDAC 拥有 IPO日期为 2025-02-20, 2 名全职员工, 在 NASDAQ Capital Marke, 市值为 $232.22M.

关于 Translational Development Acquisition Corp.

Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.

📍 77 Water St Fl 8, New York City, NY 10006 📞 16462297549
公司详情
所属板块金融服务
细分行业壳公司
国家美国
交易所NASDAQ Capital Marke
货币USD
IPO日期2025-02-20
首席执行官Michael Hoffman
员工数2
交易信息
当前价格$10.60
市值$232.22M
52周区间10.08-10.58
Beta-0.01
ETF
ADR
CUSIPG9008W105
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言